Celldex Therapeutics (CLDX) Receivables (2010 - 2026)
Celldex Therapeutics' Receivables came in at $230,000 for Q2 2026, up 155.6% from $90,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Celldex Therapeutics (CLDX) Receivables (2010 - 2026) Analysis & Trends
At the end of FY2025, Celldex Therapeutics' Receivables was $2.02 million, up 187.9% from FY2024.
- Receivables carries a five-year compound annual growth rate of 2.3% (FY2020 to FY2025).
- Going back by year, Receivables was $700,000 in FY2024 (-73.4%), $2.63 million in FY2023 (+657.3%), $347,000 in FY2022 (+101.7%) and $172,000 in FY2021 (-90.5%).
- The five-year range for quarterly Receivables is $90,000 (Q2 2025) to $2.67 million (Q1 2024).
- Year-over-year, Receivables increased in three of the last eight quarters, with growth averaging 23.3%.
- The fastest year-over-year change in Receivables over five years came in Q4 2023 (growth of 657.3%), and the weakest in Q2 2025 (a decline of 94.1%).
- Business Quant data shows CLDX's Receivables at $230,000 (Q1 2026), $2.02 million (Q4 2025) and $90,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,135.59 Bn | 1,104.17 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 616.92 Bn | 535.45 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 501.52 Bn | 474.63 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 367.36 Bn | 321.74 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 297.93 Bn | 261.92 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 261.45 Bn | 235.14 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 236.40 Bn | 191.80 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 190.72 Bn | 164.92 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 169.43 Bn | 116.08 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Celldex Therapeutics | 2.31 Bn | 35.56 Mn | - | 230,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 230,000.00 |
| Mar 31, 2026 | 230,000.00 |
| Dec 31, 2025 | 2.02 Mn |
| Sep 30, 2025 | 90,000.00 |
| Jun 30, 2025 | 90,000.00 |
| Mar 31, 2025 | 1.06 Mn |
| Dec 31, 2024 | 700,000.00 |
| Sep 30, 2024 | 852,000.00 |
| Jun 30, 2024 | 1.53 Mn |
| Mar 31, 2024 | 2.67 Mn |
| Dec 31, 2023 | 2.63 Mn |
| Sep 30, 2023 | 252,000.00 |
| Jun 30, 2023 | 118,000.00 |
| Mar 31, 2023 | 1.31 Mn |
| Dec 31, 2022 | 347,000.00 |
| Sep 30, 2022 | 189,000.00 |
| Jun 30, 2022 | 97,000.00 |
| Mar 31, 2022 | 243,000.00 |
| Dec 31, 2021 | 172,000.00 |
| Sep 30, 2021 | 197,000.00 |
API Access
Celldex Therapeutics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=CLDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "CLDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=CLDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();